In the setting of the near absence of RPS26 in human cancers, including those in the DBA patient cohort, it is worth noting some of the properties of RPS26 that set it apart from many of the other cancer-associated ribosomal proteins. This evidence concerns the gene RPS26 and Diamond-Blackfan anemia.